drugset / Trial / NCT00965055
Ezetimibe in Patients Hypo-responsive to Statins
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Response to statin therapy for elevated low density lipoprotein is variable and may be influenced by cholesterol absorption. This study will evaluate whether combination therapy with atorvastatin/ezetimibe will be superior to atorvastatin alone in subjects who have less than 25% LDL reduction on starting dose statin (eg, atorvastatin 10 mg daily or simvastatin 20 mg daily).
Timeline
- Start
- 2009-09
- Primary completion
- 2011-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | — |
| Subject | Ezetimibe | Unknown | 10 mg | — |